Digital Health

The German DiGA Market from the Investor’s Perspective Part 3: Is DiGA an interesting investment case? Investing in a DiGA manufacturer is not a straightforward case. The founder, retrospectively management team is fundamental for success, they need to have a very clear and focused Go to Market strategy in place and ideally concentrate on commercially […]

The German DiGA Market from the Investor’s Perspective Part 2: Commercial Challenges of the DiGA Business Model As part 1 of the blog series illustrates, total Rx/Revenue volume for individual DiGAs did not go through the roof in contradiction to early predictions of e.g. consultancies or investors. Even the market leader zanadio “only” achieved 28k Rx

The German DiGA Market from the Investor’s Perspective Part 1: Introduction and Status Quo of the DiGA Market in Germany September 2020 marked a turning point for the commercialization of Digital Health in Germany…and worldwide. The first fully reimbursed Digital Health Applications (DiGA: Digitale Gesundheitsanwendungen) were launched in Germany based on the Digital Healthcare Act